<DOC>
	<DOCNO>NCT01306448</DOCNO>
	<brief_summary>The study assess safety vibrate capsule healthy volunteer first constipation relief constipate individual .</brief_summary>
	<brief_title>Safety Evaluation Vibrating Capsule</brief_title>
	<detailed_description>Healthy volunteer follow safety 7 day take capsule . Constipated individual first follow 2 week use capsule 7.5 week period . Safety efficacy evaluate .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>Patients age 1860 year Ability subject understand character individual consequence clinical trial Written inform consent must available enrollment trial For woman childbearing potential , adequate contraception Patient Diverticulosis Patient must use protocoldefined prohibited medicine History current diagnosis cardiovascular ischemic disease ( e.g. , angina pectoris , myocardial infarction , transient ischemic attack stroke include finding suggestive ischemia ECG change ST segment T wave , / Q wave ) Clinical evidence significant ( judged Investigator ) respiratory , cardiovascular , renal , hepaticbiliary , endocrine , psychiatric neurologic disease presence abdominal adhesion Presents pacemaker History current eat disorder anorexia bulimia compulsory overeat . Diagnosis megarectum colon , history intestinal obstruction , congenital anorectal malformation , clinically significant rectocele , evidence intestinal structural abnormality include gastrointestinal resection affect bowel transit evidence intestinal carcinoma , inflammatory bowel disease alarm symptom weight loss , rectal bleeding , anemia . Actively participate another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>constipation</keyword>
	<keyword>gastro</keyword>
	<keyword>vibrate capsule</keyword>
	<keyword>safety</keyword>
</DOC>